$115.70
Manufacturer: Germany
Sclerotherapy of vascular meshes, varicose branches of the Central vein, reticular varicose, small, medium and large varicose nodes; hemorrhoids of the 1st and 2nd degree. Depending on the size of the varicose nodes, different concentrations of the drug are used, and Etoxisclerol 3 is used to treat hemorrhoids %
Description
Etoxisclerol Storage
active substance: lauromacrogol 400 (polidocanol);
2 ml of solution for injection contains lauromacrogol 400 – 10 mg or 20 mg or 60 mg;
excipients: ethanol 96%; sodium hydrogen phosphate, dihydrate; potassium dihydrogen phosphate; water for injections.
Etoxisclerol Dosage form
Solution for injection.
Main physical and chemical properties: clear solution from colorless to slightly greenish-yellow color.
Pharmacotherapeutic group
Sclerosing agents for local administration. ATX code C05B B02.
Pharmacological properties
Pharmacodynamics.
Lauromacrogol 400 has a sclerosing and at the same time local analgesic effect. Due to this, almost painless obliteration of varicose veins is provided. The action is directed mainly at the endothelium. Lauromacrogol 400 has a high affinity for damaged endothelium, and does not act on intact areas, so the sclerosing effect occurs only in a truly varicose veins, and not just in a cylindrically moderately dilated vein. The sclerosing effect is based on irritation of the damaged venous endothelium, which causes local thrombosis. Due to the tight fixation bandage applied after the injection, the vein walls are compressed, which prevents recanalization of the thrombus that forms, and thus the desired transformation of the thrombus into a fibrous scar. In the case of the correct choice of concentration and dosage, as well as the correct technique of treatment and care of the patient at the stage of recovery (compression treatment) lauromacrogol 400 provides a reliable and long-term obliteration.
Etoxisclerol Pharmacokinetics.
As early as 12 hours after intravenous injection of lauromacrogol 400, 89% of the administered dose is removed from the blood. As a result of the study in patients with varicose veins (diameter greater than 3 mm) after administration of Ethoxysclerol 3%, the following indicators were found: terminal half-life – 0.94-1.27 hours, volume of distribution – 17.9 liters, total clearance – 12.4 l / hour.
Indication
Sclerotherapy of vascular networks, varicose veins of the central vein, reticular varicose veins, small, medium and large varicose veins; hemorrhoids of the 1st and 2nd degree.
Depending on the size of varicose veins use different concentrations of the drug, for the treatment of hemorrhoids use Ethoxysclerol 3%.
Contraindication
In the treatment of varicose veins the drug is contraindicated in the following cases:
absolute contraindications for the use of the drug:
known hypersensitivity to lauromacrogol 400 or to other components of the drug;
acute severe systemic diseases (especially incurable);
bedridden;
obliterating endarteritis of III and IV degree;
thromboembolic disease;
high risk of thrombosis (for example, in hereditary thrombophilia or in the presence of multiple risk factors, such as hormone replacement therapy, hormonal contraceptives, obesity, smoking, all diseases and conditions that are accompanied by restriction of free movement);
absolute contraindications for the use of the drug in the form of foam (optional):
symptomatic “open oval window” in the anamnesis;
relative contraindications for the use of the drug:
Recent Reviews